Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane protein

Journal of Immunological Methods

Volumn 367, Issue 1-2, 2011, Pages 56-62

  Lemaire, Muriel M ^a,b   Vanhaudenarde, Aurélie ^a,b   Nizet, Yannick ^c   Dumoutier, Laure ^a,b   Renauld, Jean Christophe ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b DE DUVE INSTITUTE   (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Autoantibodies; Cytokine; Vaccination

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CHYMASE; CYTOKINE; DNA; HYBRID PROTEIN; INTERLEUKIN 22; INTERLEUKIN 9; MEMBRANE PROTEIN; TYPE 2 TRANSMEMBRANE PROTEIN; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CLONE; CELL SURFACE; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; IMMUNIZATION; MAST CELL; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; VACCINATION;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; HISTOCOMPATIBILITY; HUMANS; IMMUNIZATION; INTERLEUKIN-9; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; OX40 LIGAND; RECEPTORS, INTERLEUKIN; RECOMBINANT FUSION PROTEINS; VACCINES, DNA;

MUS;

EID: 79953185348     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2011.02.001     Document Type: Article

References (24)

1. Bloquel C., Trollet C., Pradines E., Seguin J., Scherman D., Bureau M.F. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol. 2006, 6:16.
2. Bontron S., Ucla C., Mach B., Steimle V. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol. Cell. Biol. 1997, 17:4249.
3. Chackerian B., Lowy D.R., Schiller J.T. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. Proc. Natl Acad. Sci. USA 1999, 96:2373.
4. Chackerian B., Lowy D.R., Schiller J.T. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest. 2001, 108:415.
5. Chackerian B., Lenz P., Lowy D.R., Schiller J.T. Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J. Immunol. 2002, 169:6120.
6. Dalum I., Butler D.M., Jensen M.R., Hindersson P., Steinaa L., Waterston A.M., Grell S.N., Feldmann M., Elsner H.I., Mouritsen S. Therapeutic antibodies elicited by immunization against TNF-alpha. Nat. Biotechnol. 1999, 17:666.
7. de Moura P.R., Watanabe L., Bleicher L., Colau D., Dumoutier L., Lemaire M.M., Renauld J.C., Polikarpov I. Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22. FEBS Lett. 2009, 583:1072.
8. Gillet L., Schroeder H., Mast J., Thirion M., Renauld J.C., Dewals B., Vanderplasschen A. Anchoring tick salivary anti-complement proteins IRAC I and IRAC II to membrane increases their immunogenicity. Vet. Res. 2009, 40:51.
9. Hauer A.D., Uyttenhove C., de Vos P., Stroobant V., Renauld J.C., van Berkel T.J., van Snick J., Kuiper J. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005, 112:1054.
10. Johnson H.E., DeAvila D.M., Chang C.F., Reeves J.J. Active immunization of heifers against luteinizing hormone-releasing hormone, human chorionic gonadotropin and bovine luteinizing hormone. J. Anim. Sci. 1988, 66:719.
11. Le Buanec H., Paturance S., Couillin I., Schnyder-Candrian S., Larcier P., Ryffel B., Bizzini B., Bensussan A., Burny A., Gallo R., Zagury D., Peltre G. Control of allergic reactions in mice by an active anti-murine IL-4 immunization. Vaccine 2007, 25:7206.
12. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H., Kishimoto T. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635.
13. Richard M., Grencis R.K., Humphreys N.E., Renauld J.C., Van Snick J. Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. Proc. Natl Acad. Sci. USA 2000, 97:767.
14. Rohn T.A., Jennings G.T., Hernandez M., Grest P., Beck M., Zou Y., Kopf M., Bachmann M.F. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 2006, 36:2857.
15. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M., Arai N. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 1988, 8:466.
16. Talwar G.P., Singh O., Pal R., Chatterjee N., Sahai P., Dhall K., Kaur J., Das S.K., Suri S., Buckshee K., et al. A vaccine that prevents pregnancy in women. Proc. Natl Acad. Sci. USA 1994, 91:8532.
17. Uyttenhove C., Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol. 2006, 36:2868.
18. Uyttenhove C., Simpson R.J., Van Snick J. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc. Natl Acad. Sci. USA 1988, 85:6934.
19. Van Pel A., De Plaen E., Boon T. Selection of highly transfectable variant from mouse mastocytoma P815. Somat. Cell Mol. Genet. 1985, 11:467.
20. Van Snick J., Goethals A., Renauld J.C., Van Roost E., Uyttenhove C., Rubira M.R., Moritz R.L., Simpson R.J. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J. Exp. Med. 1989, 169:363.
21. Vandermeulen G., Staes E., Vanderhaeghen M.L., Bureau M.F., Scherman D., Preat V. Optimisation of intradermal DNA electrotransfer for immunisation. J. Control. Release 2007, 124:81.
22. Weiss B., Wolk K., Grunberg B.H., Volk H.D., Sterry W., Asadullah K., Sabat R. Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart. Genes Immun. 2004, 5:330.
23. Zagury D., Le Buanec H., Mathian A., Larcier P., Burnett R., Amoura Z., Emilie D., Peltre G., Bensussan A., Bizzini B., Gallo R.C., Koutouzov S. IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc. Natl Acad. Sci. USA 2009, 106:5294.
24. Zuany-Amorim C., Manlius C., Dalum I., Jensen M.R., Gautam A., Pay G., Mouritsen S., Walker C. Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases. Int. Arch. Allergy Immunol. 2004, 133:154.